0001354488-17-000035.txt : 20170104
0001354488-17-000035.hdr.sgml : 20170104
20170104172828
ACCESSION NUMBER: 0001354488-17-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161230
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 787 SEVENTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 787 SEVENTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Power Sean A
CENTRAL INDEX KEY: 0001538845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 17507167
MAIL ADDRESS:
STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2016-12-30
0
0001001316
TG THERAPEUTICS, INC.
TGTX
0001538845
Power Sean A
2 GANSEVOORT ST
9TH FLOOR
NEW YORK
NY
10014
1
CFO, Secretary and Treasurer
Common Stock
2016-12-30
4
A
0
100000
0.00
A
516256
D
Common Stock
2017-01-04
4
S
0
8816
4.55
D
507440
D
Reflects a grant of restricted shares that will vest according to the following schedule: 17.5% on January 1, 2018; 17.5% on January 1, 2019; 35% on the later to occur of: (a) the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016 and (b) June 30, 2019; and 30% on performance based thresholds associated with the Company?s clinical programs.
Includes shares of restricted Common Stock, which vest over various time periods.
In connection with the vesting of 15,000 shares on January 1, 2017, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average sales price.
/s/ Sean Power
2017-01-04